Agilent Technologies Introduces eArray 3.5 to Enable Online Microarray Design Collaboration and Sharing; Content Expands Beyond Gene Expression to Include Comparative Genomic Hybridization Application.PALO ALTO Palo Alto, city, California Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries. , Calif. -- Agilent Technologies This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. Inc. (NYSE NYSE See: New York Stock Exchange :A) today announced that its pioneering, Web-based DNA microarray DNA microarray A small solid support, usually a membrane or glass slide, on which sequences of DNA are fixed in an orderly arrangement. DNA microarrays are used for rapid surveys of the expression of many genes simultaneously, as the sequences contained on a design tool, eArray, now enables the microarray industry's first collaboration and sharing capabilities wherever there is an Internet connection. Introduced in March 2005, eArray 3.0 was the industry's first Web application for designing custom DNA microarrays used in drug discovery, disease studies and basic research. The version announced today, eArray 3.5, provides an easy-to-use, secure means for sharing microarray design information among collaborators or with members of research consortia. "We expect that researchers will come to rely on eArray as a collaborative workbench and design-sharing tool for development of evolving genomes and new applications," said Mike Booth, general manager of the Genomics Group at Agilent. "This will also support researchers' efforts to publish their microarray work in peer-reviewed journals, scientific publications and presentations." In addition to existing gene expression content, annotation information and probe sequences, eArray 3.5 now provides access to Agilent's catalog array comparative genomic hybridization Array comparative genomic hybridization (also CMA, Chromosomal Microarray Analyisis, Microarray-based comparative genomic hybridization, array CGH, a-CGH, or aCGH (aCGH) probes, useful for designing microarray experiments to detect chromosome loss or duplication in cancer studies. The online tool has also been expanded to allow researchers to upload their own aCGH probes. This free tool enables users to design custom microarrays using Agilent catalog probes, probes from their own sources or a combination of both. To date, more than 300 users from 160 organizations worldwide have registered through eArray. The site helps researchers harness the inherent flexibility of Agilent's SurePrint microarray manufacturing technology in which DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. is synthesized on each slide by "inkjet" printing. This supports multiple formats and layouts, allows users to add their own content, provides built-in quality assurance probes, and facilitates updating of content. Agilent has also enhanced eArray's search capabilities to help speed microarray design. Users can access eArray 3.5 at earray.chem.agilent.com/earray. About Agilent in Genomics Agilent is a leading provider of microarray-based, genomics research solutions with more than 500 customers worldwide. Agilent's end-to-end solution (jargon) end-to-end solution - (E2ES) A term that suggests that the supplier of an application program or system will provide all the hardware and/or software components and resouces to meet the customer's requirement and no other supplier need be involved. Compare: turn-key solution. includes reagents for sample preparation and microarray processing; hardware for sample QC and high-throughput microarray scanning; 60-mer oligo microarrays on industry-standard 1" x 3" glass slides for gene expression; comparative genomic hybridization hybridization /hy·brid·iza·tion/ (hi?brid-i-za´shun) 1. crossbreeding; the act or process of producing hybrids. 2. molecular hybridization 3. and chromatin immunoprecipitation Chromatin immunoprecipitation (ChIP) assay, is a method used for experiments in molecular biology. The purpose of this assay is to determine whether proteins including (but not limited to) transcription factors bind to a particular region on the endogenous chromatin of applications; custom microarray design services; and industry-leading GeneSpring and Rosetta software products for data analysis. About Agilent Technologies Agilent Technologies Inc. (NYSE:A) is the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company's 28,000 employees serve customers in more than 110 countries. Agilent had net revenue of $7.2 billion in fiscal year 2004. Information about Agilent is available on the Web at www.agilent.com. NOTE TO EDITORS: Press releases, photography and other information can be accessed on the Agilent Life Sciences and Chemical Analysis newsroom at www.agilent.com/about/newsroom/lsca. Further technology, corporate citizenship Corporate Citizenship The extent to which businesses are socially responsible in meeting legal, ethical and economic responsibilities placed on them by shareholders. The aim it to create higher standards of living and quality of life in the community in which it operates, while and executive news is available on the Agilent news site at www.agilent.com/go/news. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion